Medicare Enrolled
Dr. Selena Stuart, M.D.
Internal Medicine · New Braunfels, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Stuart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stuart?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Stuart
Dr. Selena Stuart is an internal medicine specialist in New Braunfels, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Stuart performed 113,052 Medicare services across 4,993 unique beneficiaries.
Between the years covered by Open Payments, Dr. Stuart received a total of $9,291 from 45 pharmaceutical and/or device companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stuart is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 0% volume in TX
$9,291 industry payments
Medicare Practice Summary
Medicare Utilization ↗113,052
Medicare services
Top 0% in TX for internal medicine
4,993
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,650 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 18,300 | $43 | $136 |
| Anti-nausea injection (fosaprepitant) | 16,800 | $0 | $5 |
| Oxaliplatin chemotherapy injection | 16,300 | $0 | $33 |
| Iron infusion (Feraheme) | 13,260 | $0 | $5 |
| Iron sucrose injection (Venofer) | 10,500 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 9,317 | $0 | $3 |
| Immune globulin infusion (Octagam) | 4,830 | $34 | $233 |
| Dexamethasone injection (steroid) | 2,586 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 2,040 | $19 | $66 |
| Injection, atropine sulfate, 0.01 mg | 1,920 | $0 | $1 |
| Blood draw (venipuncture) | 1,727 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,669 | $8 | $36 |
| Comprehensive metabolic blood panel | 1,505 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,460 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 1,030 | $0 | $24 |
| Injection, fluorouracil, 500 mg | 756 | $2 | $13 |
| Office visit, established patient (30-39 min) | 696 | $92 | $368 |
| Office visit, established patient (20-29 min) | 593 | $63 | $250 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 585 | $22 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 484 | $97 | $707 |
| Flow cytometry, additional marker | 427 | $18 | $180 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 391 | $269 | $2,762 |
| Drug injection, under skin or into muscle | 374 | $10 | $96 |
| Carcinoembryonic antigen (cea) protein level | 358 | $18 | $99 |
| Injection, zoledronic acid, 1 mg | 305 | $6 | $431 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 281 | $20 | $128 |
| Measurement of immunoglobulin light chains | 236 | $17 | $60 |
| Lactate dehydrogenase (enzyme) level | 217 | $6 | $31 |
| Immunoglobulin level test | 216 | $9 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 214 | $47 | $313 |
| Ferritin level test (iron stores) | 211 | $13 | $60 |
| Iron level test | 202 | $6 | $27 |
| Iron binding capacity test | 202 | $9 | $35 |
| Injection, carboplatin, 50 mg | 199 | $2 | $300 |
| Administration of chemotherapy into vein, each additional hour | 163 | $21 | $161 |
| Reticulated (young) platelet measurement | 149 | $35 | $143 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 144 | $54 | $211 |
| Complete blood count (CBC), automated | 142 | $6 | $34 |
| Microscopic examination for white blood cells with manual cell count | 141 | $4 | $22 |
| Administration of additional new drug or substance into vein, 1 hour or less | 134 | $48 | $344 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 128 | $174 | $700 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 123 | $25 | $145 |
| Injection, diphenhydramine hcl, up to 50 mg | 123 | $1 | $7 |
| Irrigation of implanted venous access drug delivery device | 114 | $18 | $114 |
| Office visit, established patient, complex (40-54 min) | 105 | $129 | $496 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 97 | $131 | $3,675 |
| Ct scan of chest with contrast | 95 | $48 | $821 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 88 | $123 | $500 |
| CT scan of abdomen and pelvis with contrast | 84 | $168 | $1,067 |
| Injection of additional new drug or substance into vein | 74 | $11 | $108 |
| PSA test (prostate cancer screening) | 71 | $18 | $94 |
| Thyroid stimulating hormone (TSH) test | 71 | $16 | $80 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 71 | $16 | $100 |
| Unclassified drugs | 71 | $1 | $8 |
| Vitamin B-12 level test | 68 | $15 | $76 |
| Folic acid level test | 67 | $14 | $73 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 64 | $91 | $657 |
| Infusion, normal saline solution , 1000 cc | 55 | $2 | $19 |
| New patient office visit (45-59 min) | 52 | $116 | $565 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 51 | $1,112 | $4,802 |
| New patient office visit (30-44 min) | 32 | $75 | $372 |
| Administration of additional new drug or substance into vein using push technique | 28 | $39 | $289 |
| New patient office visit, complex (60-74 min) | 28 | $168 | $709 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 28 | $178 | $700 |
| CT scan of chest, without contrast | 27 | $40 | $686 |
| Protein measurement, serum | 23 | $11 | $99 |
| Immunologic analysis technique on serum (immunofixation) | 22 | $22 | $160 |
| Drawing of blood for a medical problem | 21 | $53 | $264 |
| Ct scan of abdomen and pelvis without contrast | 18 | $79 | $560 |
| Flow cytometry technique for dna or cell analysis, first marker | 17 | $56 | $298 |
| Infusion into a vein for hydration, 31-60 minutes | 16 | $23 | $256 |
| Ct scan of soft tissue of neck with contrast | 15 | $69 | $658 |
| Nuclear medicine study whole body with ct scan | 15 | $1,111 | $4,929 |
| Urinalysis with microscopic exam | 15 | $3 | $28 |
| Red blood count automated, with additional calculations | 11 | $5 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.9% high complexity
73.8% medium
9.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,291
Total received (2018-2024)
Avg $1,327/year across 7 years
Top 9% in TX for internal medicine
45
Companies
405
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,137 (76.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,749 (18.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$404 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$626
2023
$192
2022
$681
2021
$386
2020
$445
2019
$3,935
2018
$3,025
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,064
E.R. Squibb & Sons, L.L.C.
$1,082
Amgen Inc.
$787
PFIZER INC.
$774
Novartis Pharmaceuticals Corporation
$632
AstraZeneca Pharmaceuticals LP
$271
Rigel Pharmaceuticals, Inc.
$243
Genentech USA, Inc.
$239
Astellas Pharma US Inc
$238
Merck Sharp & Dohme Corporation
$213
Celgene Corporation
$211
Janssen Scientific Affairs, LLC
$191
Lilly USA, LLC
$180
Boehringer Ingelheim Pharmaceuticals, Inc.
$153
EISAI INC.
$148
Teva Pharmaceuticals USA, Inc.
$139
Medtronic, Inc.
$131
Kite Pharma, Inc.
$130
Puma Biotechnology, Inc.
$129
Takeda Pharmaceuticals U.S.A., Inc.
$124
Davol Inc.
$119
Verastem, Inc.
$116
Bayer HealthCare Pharmaceuticals Inc.
$87
AbbVie, Inc.
$86
Regeneron Healthcare Solutions, Inc.
$82
Seattle Genetics, Inc.
$77
Array BioPharma Inc.
$76
Gilead Sciences, Inc.
$69
GlaxoSmithKline, LLC.
$67
GENZYME CORPORATION
$66
Pharmacyclics LLC, An AbbVie Company
$48
AMAG Pharmaceuticals, Inc.
$42
Dova Pharmaceuticals
$32
TOLMAR Pharmaceuticals, Inc.
$31
EMD Serono, Inc.
$31
TESARO, Inc.
$29
Exelixis Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$23
Janssen Pharmaceuticals, Inc
$22
Eisai Inc.
$19
ADC Therapeutics America, Inc.
$17
Karyopharm Therapeutics Inc.
$15
Tactile Systems Technology Inc
$13
Seagen Inc.
$13
Clovis Oncology, Inc.
$5
Top 3 companies account for 42.3% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · Abraxane · Aliqopa · Avastin · BALVERSA · BENDEKA · BLENREP · BOSULIF · Balversa · Bavencio · Braftovi · CALQUENCE · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENJAYMO · ERLEADA · Erleada · FERAHEME · Flexitouch Plus · GILOTRIF · Halaven · IBRANCE · IMFINZI · INLYTA · Imbruvica · JADENU · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KYPHON EXPRESS II KYPHOPAK TRAY · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OPDIVO · PIQRAY · PROMACTA · Perjeta · Pomalyst · Progel Applicator Spray Tips · Prolia · REBLOZYL · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SPRYCEL · SUTENT · Stivarga · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · VOTRIENT · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Yescarta · ZEJULA · ZYTIGA · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in TX.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
115
Per 100K population
64.5
County median income
$93,776
Nearest hospital
RESOLUTE HEALTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Stuart is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement in the top 9% of TX peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Stuart experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Stuart performed 18,300 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stuart receive payments from pharmaceutical companies?
Yes. Dr. Stuart received a total of $9,291 from 45 companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stuart's costs compare to other internal medicine physicians in New Braunfels?
Dr. Stuart's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stuart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in New Braunfels
Browse internal medicine physicians in New Braunfels ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology